Ramkhamhaeng Hospital PCL

Ramkhamhaeng Hospital PCL maintains a debt-to-equity ratio of 0.84, indicating a moderate level of leverage, and a current ratio of 0.45, suggesting potential liquidity constraints. The company's liquidity position is assessed as medium, with free cash flow of 2.82 billion THB and operating cash flow of 2.55 billion THB, but with only 6.85 million THB in cash and equivalents. In terms of profitability, the company reports a return on equity of 12.83% and a return on assets of 4.39%, which are key metrics for evaluating performance in the healthcare industry. These figures suggest that the company is generating reasonable returns relative to its equity and asset base, though the return on assets is relatively modest. The company's revenue is concentrated in its core healthcare services, with no disclosed segment breakdown. Geographically, the company operates primarily in Thailand, and there is no indication of significant international exposure. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the current or next fiscal year. The operating income of 3.26 billion THB and net income of 2.80 billion THB indicate a consistent earnings pattern. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could pose challenges in the event of unexpected cash flow needs. However, the low dilution risk suggests that the company is not likely to issue additional shares in the near term, preserving shareholder value. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. Analysts have provided a mean price target of 19.00 THB, with a single "hold" recommendation and no "buy" or "strong buy" ratings.